Eastern Hepatobiliary Surgery Hospital
🇨🇳China
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02724475
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
Completed
- Conditions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT02724345
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT02724358
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02724436
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Targeted Internal Radiation Therapy in Advanced HCC Patients.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02724267
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02588755
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02587884
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma
- First Posted Date
- 2015-10-26
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02586285
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT02525952
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 194
- Registration Number
- NCT02525965
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath